Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

BACKGROUND: Thalidomide is active in multiple myeloma and is associated with minimal myelosuppression, making it a good candidate for induction therapy prior to high-dose therapy with autologous stem-cell transplantation. DESIGN AND METHODS: Oral cyclophosphamide, thalidomide, and dexamethasone was...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Morgan, Gareth J., Davies, Faith E., Gregory, Walter M., Bell, Sue E., Szubert, Alexander J., Navarro Coy, Nuria, Cook, Gordon, Feyler, Sylvia, Johnson, Peter R.E., Rudin, Claudius, Drayson, Mark T., Owen, Roger G., Ross, Fiona M., Russell, Nigel H., Jackson, Graham H., Child, J. Anthony
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ferrata Storti Foundation 2012
Onderwerpen:
Original Articles and Brief Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291601/
https://ncbi.nlm.nih.gov/pubmed/22058209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.043372
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items